• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. AstraZeneca

AstraZeneca

Page 12 of 13

The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health

Merck to Axe Jobs As Part of New Research Focus

By Research Team
July 13, 2016
13-year-old Sean Monett, a seventh grader at South Doyle Mid
Health

The Feds Say This Popular Nasal Spray Flu Vaccine Doesn’t Work

By Crypto Correspondent
June 23, 2016
Here’s How Drug Prices Actually Work
Finance

Here’s How Drug Prices Actually Work

By Crypto Correspondent
April 26, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

AstraZeneca Is Eyeing This San Francisco Drugmaker

By Trading Desk
April 18, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

AstraZeneca Continues to Sell Off Its Drug Portfolio

By Investment Desk
March 1, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

Astrazeneca Gets European Approval for Its New Lung Cancer Drug

By Contributing Writer
February 3, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

AstraZeneca Wants a Stake in This Biotech Firm for a Cancer Cure

By Senior Editor
December 17, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

Astrazeneca is Buying ZS Pharma for $2.7 billion

By Trading Desk
November 6, 2015
Microsoft Unveils New Devices Powered By Windows 10
Tech

Microsoft wants its new Surface to invade offices everywhere

By Trading Desk
October 20, 2015
Coins2Day
Finance

Are U.S. corporate tax inversions a necessary crisis?

By News Correspondent
July 18, 2014
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

AstraZeneca fails to win FDA panel backing for cancer treatment

By Blockchain Reporter
June 26, 2014
AstraZeneca shareholders upset by “quick” Pfizer rejection
Finance

AstraZeneca shareholders upset by “quick” Pfizer rejection

By News Correspondent
May 20, 2014
Coins2Day
Finance

AstraZeneca rejects higher ‘final’ offer from Pfizer

By Tech Reporter
May 19, 2014
Does the AstraZeneca-Pfizer deal make scientific sense?
Features

Does the AstraZeneca-Pfizer deal make scientific sense?

By Market Analyst
May 15, 2014
Pfizer admits to potential job losses in AstraZeneca takeover

Pfizer admits to potential job losses in AstraZeneca takeover

By Crypto Correspondent
May 13, 2014

Most Popular

  • AI
    Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
    By Trading Desk
  • Economy
    One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
    By Staff Writer
  • Economy
    Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
    By Blockchain Reporter
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.